Multivalent diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine
(DTaP/IPV) has been offered to pregnant women in the United Kingdom since 2012. To …

Background Intradermal administration of fractional inactivated poliovirus vaccine (fIPV) is a
dose-sparing alternative to the intramuscular full dose. We aimed to compare the …

Background Following the proposed worldwide switch from trivalent oral poliovirus vaccine
(tOPV) to bivalent types 1 and 3 OPV (bOPV) in 2016, inactivated poliovirus vaccine (IPV) …

Background A dose-sparing inactivated polio vaccine (IPV-Al), obtained by adsorption of
inactivated virus to an aluminium hydroxide adjuvant, can help mitigate global supply and …

BACKGROUND: Oral poliovirus vaccine (OPV) remains the vaccine-of-choice for routine
immunization and supplemental immunization activities (SIAs) to eradicate poliomyelitis …

The presence of maternal poliovirus antibodies may interfere with the immune response to
inactivated polio vaccine (IPV), and its influence on the safety of vaccination is not yet …

Background Quantifying interference of maternal antibodies with immune responses to
varying dose schedules of inactivated polio vaccine (IPV) is important for the polio endgame …

Introduction Replacing live-attenuated oral poliovirus vaccines (OPV) with inactivated
poliovirus vaccines (IPV) is part of the global strategy to eradicate poliomyelitis. China was …

Background The polio eradication endgame required the withdrawal of Sabin type 2 from
the oral poliovirus vaccine and introduction of one or more dose of inactivated poliovirus …

Background Following the global eradication of wild poliovirus, countries using live
attenuated oral poliovirus vaccines will transition to exclusive use of inactivated poliovirus …